The first Esperion Therapeutics trade was made in Q4 2022. Since then Jefferies Group bought shares one more times and sold shares on five occasions. The investor sold all their shares in Q2 2024 and doesn't own any shares in Esperion Therapeutics anymore.
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares...
ESPR has seen its SMA50 which is now -21.95%. In looking the SMA 200 we see that the stock has seen a -27.65%. GNS has seen its SMA50 which is … The post Gra...
Man Group plc cut its holdings in shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR) by 50.8% in the 2nd quarter, according to the company in its most recen...
Vanguard Group Inc. trimmed its position in shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR) by 0.8% in the 2nd quarter, according to the company in its m...